Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial, (Front. Med, (2022), 9, (936126), 10.3389/fmed.2022.936126)

Andreas Heinzel; Eva Schrezenmeier; Florina Regele; Karin Hu; Lukas Raab; Michael Eder; Christof Aigner; Rhea Jabbour; Constantin Aschauer; Ana Luisa Stefanski; Thomas Dörner; Klemens Budde; Roman Reindl-Schwaighofer; Rainer Oberbauer

ArticleOPEN ACCESS

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial, (Front. Med, (2022), 9, (936126), 10.3389/fmed.2022.936126)

Frontiers in Medicine

DOI: 10.3389/fmed.2022.1048395

1Citations

5Readers

Abstract

In the published article, an author name was incorrectly written as “Schretzenmeier.” The correct spelling is “Schrezenmeier.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Author supplied keywords

Cite

CITATION STYLE

APA

Heinzel, A., Schrezenmeier, E., Regele, F., Hu, K., Raab, L., Eder, M., … Oberbauer, R. (2022, October 10). Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial, (Front. Med, (2022), 9, (936126), 10.3389/fmed.2022.936126). Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2022.1048395

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial, (Front. Med, (2022), 9, (936126), 10.3389/fmed.2022.936126)

Abstract

Author supplied keywords

Cite

Register to see more suggestions